A new study from experts at the University of Exeter has found that a widely used test for prostate cancer may leave black men at increased risk of overdiagnosis.
Intercept’s liver disease drug Ocaliva faces FDA approval delay – Pharmaceutical Technology
The original FDA full approval decision date was 15 October, but this has been delayed. Credit: Tada Images via Shutterstock. Intercept Pharmaceuticals will have to
October 21, 2024